Fair enough plough.
I actually think DYE's strategic management is pretty good. Recent funding arrangements would suggest institutional investors think it's pretty good too. What I (and others on this forum) have a huge problem with is Investor Relations. Imo the quality of DYE's reporting is appalling. There seems to be very little interest in keeping retail investors informed. Hopefully the SP response to the CR will send a clear message that this needs to change. Asking us for money whilst keeping us in the dark isn't going to work.
If it does decide to get serious about reporting, DYE should take a look at PRR's Quarterly Reports. Each QR is well laid out with a clearly explained list of achievements for the quarter. No waffle, no ambiguity, no typos - just concise, usable information. PRR seems to have a genuine interest in keeping its investors fully informed. It's no surprise that the CEO's happy to put his name to them.
Here's an example:
http://www.asx.com.au/asxpdf/20100127/pdf/31nbmdkl8qz9l0.pdf
- Forums
- ASX - By Stock
- GSL
- hi!
hi!, page-10
Featured News
Add GSL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online